Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

A task force of law enforcement officials in Louisiana was able to confiscate thousands of pain pills after information was ...

The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a first-in-class non-opioid analgesic—to treat moderate to severe acute pain in adults.

Opioids are a class of drugs that “derive from, or mimic, natural substances found in the opium poppy plant”, according to the website of the US-based Johns Hopkins Medicine. Some common opioids ...

A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...